Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASCO GU 2016: Highlights

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.01.16
Views: 2556
Rating:

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

Dr Choueiri talks to ecancertv at the ASCO GU 2016 meeting about updates in prostate and renal cancer presented at the meeting.

Dr Choueiri discusses the recent data from the subgroup analyses of METEOR and the results from the CheckMate 025 phase III trial, as well as covering some updates in renal and testicular cancer.

 

Related videos

follow us

Immuno-oncology advances in cancer treatment e-learning


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation